3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Myoclonus: new trials by email Literature Review of Myoclonus trials Research Report on Myoclonus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Dexamethasone acetate, dexamethasone and cyclophosphamide, dexamethasone and rituximab - Opsoclonus Myoclonus Syndrome, Neuroblastoma | Phase 3 | Completed | Institut Curie | 102 | 2013-04-18 | 2025-02-03 |
| Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults Brivaracetam 25 mg, Brivaracetam 50 mg, Placebo - Unverricht-Lundborg Disease | Phase 3 | Completed | UCB Pharma SA | 50 | 2006-11-01 | 2015-05-18 |
| Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults Placebo, BRV 2.5 mg, BRV 25 mg - Unverricht-Lundborg Disease | Phase 3 | Completed | UCB Pharma | 56 | 2006-11-01 | 2023-05-31 |
Myoclonic Epilepsies, Progressive (2) · Unverricht-Lundborg Syndrome (2) · Neuroblastoma (1) · Opsoclonus-Myoclonus Syndrome (1)
Central Nervous System Diseases (3) · Dyskinesias (3) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Neurologic Manifestations (3) · Brain Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Epilepsies, Myoclonic (2) · Epilepsy (2) · Epilepsy, Generalized (2) · Epileptic Syndromes (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
brivaracetam (2) · Cyclophosphamide (1) · Dexamethasone (1) · Rituximab (1) · dexamethasone acetate (1)
Institut Curie (1) · UCB Pharma (1) · UCB Pharma SA (1)
France (3) · Finland (2) · Italy (2) · Sweden (2) · Tunisia (2) · Austria (1) · Canada (1) · Israel (1) · Netherlands (1) · Reunion (1) · Russia (1) · Serbia (1) · Spain (1) · Switzerland (1) · United Kingdom (1)